Immunology

Molecular 'culprit' caught driving cell death and inflammation

A WEHI-led study has identified a molecular 'culprit' responsible for causing damaging levels of cell death and inflammation in the body. The findings could lead to improved treatment options for a range of conditions driven ...

Medications

Added benefit of linagliptin is not proven

Linagliptin (trade name: Trajenta) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled ...

Oncology & Cancer

How sound waves trigger immune responses to cancer in mice

When non-invasive sound waves break apart tumors, they trigger an immune response in mice. By breaking down the cell wall "cloak," the treatment exposes cancer cell markers that had previously been hidden from the body's ...

page 12 from 40